Neurimmune Holding
Neurimmune develops innovative immunotherapeutics for human diseases.
Neurimmune Holding is a business in biotechnology, information technology, pharmaceutical based in Europe, Middle East, and Africa (EMEA), founded in 2006.
Its activity falls under biotechnology, information technology, pharmaceutical; the profile below is assembled from public directory data.
Its base of operations is Europe, Middle East, and Africa (EMEA).
Directory data places it at the Series_Unknown stage.
The company reports a headcount in the c_00051_00100 range.
Total disclosed funding stands at about $150M.
| Sector | Biotechnology, Information Technology, Pharmaceutical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2006 |
| Employees | c_00051_00100 |
| Stage | series_unknown |
| Total funding | $150,000,000 |
Website: www.neurimmune.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account